全文获取类型
收费全文 | 152347篇 |
免费 | 14486篇 |
国内免费 | 8449篇 |
专业分类
耳鼻咽喉 | 1227篇 |
儿科学 | 2059篇 |
妇产科学 | 1689篇 |
基础医学 | 22728篇 |
口腔科学 | 2725篇 |
临床医学 | 17910篇 |
内科学 | 22179篇 |
皮肤病学 | 2107篇 |
神经病学 | 7704篇 |
特种医学 | 5462篇 |
外国民族医学 | 65篇 |
外科学 | 15153篇 |
综合类 | 23395篇 |
现状与发展 | 29篇 |
一般理论 | 14篇 |
预防医学 | 9969篇 |
眼科学 | 3581篇 |
药学 | 17301篇 |
120篇 | |
中国医学 | 7813篇 |
肿瘤学 | 12052篇 |
出版年
2024年 | 453篇 |
2023年 | 2032篇 |
2022年 | 5060篇 |
2021年 | 7367篇 |
2020年 | 5341篇 |
2019年 | 4855篇 |
2018年 | 5089篇 |
2017年 | 4681篇 |
2016年 | 4516篇 |
2015年 | 6480篇 |
2014年 | 8044篇 |
2013年 | 7893篇 |
2012年 | 11138篇 |
2011年 | 11769篇 |
2010年 | 8216篇 |
2009年 | 6615篇 |
2008年 | 8114篇 |
2007年 | 8135篇 |
2006年 | 7427篇 |
2005年 | 6784篇 |
2004年 | 5392篇 |
2003年 | 5255篇 |
2002年 | 4487篇 |
2001年 | 3823篇 |
2000年 | 3324篇 |
1999年 | 2937篇 |
1998年 | 1779篇 |
1997年 | 1881篇 |
1996年 | 1374篇 |
1995年 | 1266篇 |
1994年 | 1146篇 |
1993年 | 816篇 |
1992年 | 1182篇 |
1991年 | 1106篇 |
1990年 | 1017篇 |
1989年 | 944篇 |
1988年 | 865篇 |
1987年 | 757篇 |
1986年 | 720篇 |
1985年 | 625篇 |
1984年 | 515篇 |
1983年 | 398篇 |
1982年 | 321篇 |
1981年 | 284篇 |
1980年 | 231篇 |
1979年 | 308篇 |
1978年 | 249篇 |
1977年 | 258篇 |
1976年 | 234篇 |
1974年 | 197篇 |
排序方式: 共有10000条查询结果,搜索用时 125 毫秒
101.
102.
Wen Wang Yanmei Liu Chuan Yu Jing Tan Weiyi Xiong Duo Dong 《Expert opinion on drug safety》2020,19(3):339-347
ABSTRACTObjectives: Limited evidence has suggested that cefoperazone-sulbactam causes coagulation disorders and bleeding.Methods: The authors conducted a retrospective study to compare patients receiving cefoperazone-sulbactam versus those treated with cefoperazone-tazobactam or ceftazidime. Propensity-score matching was used to explore whether treatment with cefoperazone-sulbactam increased the risk of prothrombin time (PT) prolongation, coagulation disorders, and bleeding, or decreased platelets (PLT).Results: The cohort included 23,242 patients. Among patients receiving cefoperazone-sulbactam, the risk of PT prolongation, coagulation disorders, decreased PLT, and bleeding was 5.3%, 9.2%, 15.7%, and 4.2%, respectively. Propensity-score matching analyses suggested that cefoperazone-sulbactam increased the risk of PT prolongation (aOR 2.26, 95% CI 1.61–3.18), coagulation disorders (aOR 1.81, 95% CI 1.43–2.30), and decreased PLT (aOR 1.46, 95% CI 1.25–1.72), but not increase bleeding (aOR 1.05, 95% CI 0.79–1.40) compared with ceftazidime. Patients receiving cefoperazone-sulbactam had higher risk of PT prolongation (aOR 1.53, 95% CI 1.11–2.10), coagulation disorders (aOR 1.53, 95% CI 1.21–1.95), but not decreased PLT (aOR 0.93, 95% CI 0.81–1.07) or bleeding (aOR 1.11, 95% CI 0.87–1.42), compared with those receiving cefoperazone-tazobactam.Conclusion: Cefoperazone-sulbactam may be associated with a higher risk of PT prolongation and coagulation disorders compared with cefoperazone-tazobactam and ceftazidime. 相似文献
103.
104.
105.
106.
患者,女,57岁。躯干部白色丘疹3年。本例皮肤镜表现独特之处在偏振光浸润模式下与典型脂溢性角化病不同,由于色素减退,皮沟与皮嵴表现为浅褐色背景下放射状分布亮白色线状条纹,呈珊瑚样结构。 相似文献
107.
108.
起搏治疗遗传性长QT间期综合征23例 总被引:3,自引:0,他引:3
目的:评价VVI起搏治疗遗传性长QT综合征的疗效. 方法:对23例有尖端扭转性室速发作,且经正规药物治疗无效或无法耐受的遗传性长QT综合征患者,植入了VVI起搏器.随访这23例患者术后心电图及心脏事件发生率. 结果:QT间期平均值由术前(638.0±55.7)ms缩短至术后的(471.3±48.9)ms,QTc平均值为由0.627±0.07缩短至0.519±0.06.心脏事件的发生率由术前的(0.353±0.46)次/年降至术后(0.111±0.24)次/年,(P=0.039).其中77.5%的患者随访期间无晕厥或猝死等心脏事件发生.90.91%患者存活.2例患者因尖端扭转性室速恶化为室颤抢救无效死亡. 结论:VVI起搏治疗可以有效地减少长QT综合征患者恶性心律失常的发生,是治疗长QT综合征的重要方法之一. 相似文献
109.
Takaharu Negoro Kanami Orihara Tomoko Irahara Hiroshi Nishiyama Kanae Hagiwara Risa Nishida Hiroki Takagi Kazue Satoh Yoshiki Yamamoto Shunichi Shimizu Tamio Hagiwara Masakazu Ishii Toshihiro Tanioka Yasuko Nakano Ken Takeda Isao Yoshimura Yoji Iikura Takashi Tobe 《Pediatric allergy and immunology》2006,17(8):583-590
Although many single nucleotide polymorphism (SNP) studies have reported an association of atopy, allergic diseases and total serum immunoglobulin E (IgE) levels, almost all of these studies sought risk factors for the onset of these allergic diseases. Furthermore, many studies have analyzed a single gene and hardly any have analyzed environmental factors. In these analyses, the results could be masked and the effects of other genes and environmental factors may be decreased. Here, we described the correlation between four genes [interleukin (IL)-4 (C-590T), IL-4 receptor (A1652G), FCER1B (G6842A) and STAT6 (G2964A)] in connection with IgE production; the role of IL-10 (C-627A) as a regulatory cytokine of allergy; and the severity of food allergy (FA) and atopic eczema (AE) in 220 Japanese allergic children. In addition to these SNPs, environmental factors, i.e., patient's attitude, indoor environment, and so on, were also investigated in this study. Our study was retrospective, and the correlation was analyzed by our defined clinical scores divided into three terms: worst symptoms, recent symptoms and general amelioration at the most recent examination during the disease course. Our results indicated that IL-10 AA, the genotype with lower IL-10 production, is associated with higher IgE levels in the serum (p < 0.0001, estimate; 0.912). Marginal liver abnormalities were observed in the subject group with both FA and AE (p < 0.1191, estimate; 0.1490). Our defined clinical scores enabled evaluation of various aspects of disease severity. Based on the scores, while no single SNP selected in this study determined severity, the combination of the SNP with laboratory data and environmental factors appeared to determine severity. 相似文献
110.
目的:通过对21例髋臼爆裂性骨折伴股骨头脱位的手术治疗,探讨处理此类损伤应注意的几个问题。方法:术前 X片及CT片明确骨折及脱位类型,采用患侧扩大的髂股入路或Langenbeck-Kocher入路,显露髂骨内外板及小骨盆内壁、髋臼前后柱,必要时显露坐骨大切迹,保持股骨头于脱位状态,直视下复位各骨折块尽量达到髓关节内软骨面光滑圆弧,在骨折复位状态下行内固定,之后使股骨头复位入髋臼,术后皮牵引,早期锻炼。结果:术后21例随访12~36个月, 骨折均愈合好,髋臼内壁形态光滑,元再脱位或创伤性关节炎症状出现。结论:髋臼爆裂性骨折伴股骨头脱位的病例,早期手术恢复髋臼内壁软骨面光滑圆弧可最大限度的恢复患肢功能,能有效地防止髓关节创伤性关节炎的发生,手术切口的选择是复位成功的关键,同时深静脉栓塞、坐骨神经的损伤及异位骨化的预防应予以重视。 相似文献